Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease

Authors Ismail MF, ElMeshad A, Salem N

Received 18 October 2012

Accepted for publication 2 December 2012

Published 23 January 2013 Volume 2013:8(1) Pages 393—406


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Manal Fouad Ismail,1 Aliaa Nabil ElMeshad,2 Neveen Abdel-Hameed Salem3

1Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 3Department of Narcotics and Ergogenic Aids and Poisons, National Research Center, Giza, Egypt

Background: To sustain the effect of rivastigmine, a hydrophilic cholinesterase inhibitor, nanobased formulations were prepared. The efficacy of the prepared rivastigmine liposomes (RLs) in comparison to rivastigmine solution (RS) was assessed in an aluminium chloride (AlCl3)-induced Alzheimer’s model.
Methods: Liposomes were prepared by lipid hydration (F1) and heating (F2) methods. Rats were treated with either RS or RLs (1 mg/kg/day) concomitantly with AlCl3 (50 mg/kg/day).
Results: The study showed that the F1 method produced smaller liposomes (67.51 ± 14.2 nm) than F2 (528.7 ± 15.5 nm), but both entrapped the same amount of the drug (92.1% ± 1.4%). After 6 hours, 74.2% ± 1.5% and 60.8% ± 2.3% of rivastigmine were released from F1 and F2, respectively. Both RLs and RS improved the deterioration of spatial memory induced by AlCl3, with RLs having a superior effect. Further biochemical measurements proved that RS and RLs were able to lower plasma C-reactive protein, homocysteine and asymmetric dimethylarginine levels. RS significantly attenuated acetylcholinesterase (AChE) activity, whereas Na+/K+-adenosine triphosphatase (ATPase) activity was enhanced compared to the AlCl3-treated animals; however, RLs succeeded in normalization of AChE and Na+/K+ ATPase activities. Gene-expression profile showed that cotreatment with RS to AlCl3-treated rats succeeded in exerting significant decreases in BACE1, AChE, and IL1B gene expression. Normalization of the expression of the aforementioned genes was achieved by coadministration of RLs to AlCl3-treated rats. The profound therapeutic effect of RLs over RS was evidenced by nearly preventing amyloid plaque formation, as shown in the histopathological examination of rat brain.
Conclusion: RLs could be a potential drug-delivery system for ameliorating Alzheimer's disease.

Keywords: rivastigmine, Alzheimer’s disease, liposomes, rats, gene expression

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4

Shiozaki Y, Kitajima T, Mazaki T, Yoshida A, Tanaka M, Umezawa A, Nakamura M, Yoshida Y, Ito Y, Ozaki T, Matsukawa A

International Journal of Nanomedicine 2013, 8:1349-1360

Published Date: 9 April 2013

Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy

Li C, Zhang X, Huang X, Wang X, Liao G, Chen Z

International Journal of Nanomedicine 2013, 8:1285-1292

Published Date: 24 March 2013

Responsiveness of voltage-gated calcium channels in SH-SY5Y human neuroblastoma cells on quasi-three-dimensional micropatterns formed with poly (l-lactic acid)

Wu ZZ, Wang ZW, Zhang LG, An ZX, Zhong DH, Huang QP, Luo MR, Liao YJ, Jin L, Li CZ, Kisaalita WS

International Journal of Nanomedicine 2013, 8:93-107

Published Date: 3 January 2013

Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy

Cruz-Bustos T, González-González G, Morales-Sanfrutos J, Megí­a-Fernández A, Santoyo-González F, Osuna A

International Journal of Nanomedicine 2012, 7:5941-5956

Published Date: 3 December 2012

Antibacterial hemostatic dressings with nanoporous bioglass containing silver

Hu G, Xiao L, Tong P, Bi D, Wang H, Ma H, Zhu G, Liu H

International Journal of Nanomedicine 2012, 7:2613-2620

Published Date: 28 May 2012

Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy

Woo HN, Chung HK, Ju EJ, Jung J, Kang HW, Lee SW, Seo MH, Lee JS, Lee JS, Park HJ, Song SY, Jeong SY, Choi EK

International Journal of Nanomedicine 2012, 7:2197-2208

Published Date: 27 April 2012

Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm

Hernandez-Delgadillo R, Velasco-Arias D, Diaz D, Arevalo-Niño K, Garza-Enriquez M, De la Garza-Ramos MA, Cabral-Romero C

International Journal of Nanomedicine 2012, 7:2109-2113

Published Date: 24 April 2012